NANOPORTAL Trademark

Trademark Overview


On Tuesday, April 26, 2022, a trademark application was filed for NANOPORTAL with the United States Patent and Trademark Office. The USPTO has given the NANOPORTAL trademark a serial number of 97382032. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, December 19, 2024. This trademark is owned by Second Sight Medical Products, Inc.. The NANOPORTAL trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy

Nanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant

Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy del...

General Information


Serial Number97382032
Word MarkNANOPORTAL
Filing DateTuesday, April 26, 2022
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, December 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesImplantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy
Goods and ServicesNanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant
Goods and ServicesImplantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSecond Sight Medical Products, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSylmar, CA 91342

Trademark Events


Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022NEW APPLICATION ENTERED
Monday, February 13, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 15, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 30, 2023SUSPENSION LETTER WRITTEN
Tuesday, May 30, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, November 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 19, 2024NON-FINAL ACTION WRITTEN
Thursday, December 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 19, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION